赛生药业（06600）公布，于2024年5月7日，根据首次公开发售后购股权计划的规则：根据首次公开发售后购股权计划授出的7000份购股权已失效；及根据首次公开发售后购股权计划授出的9万份购股权已获行使。
赛生药业公布授出的9万份购股权已获行使
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.